Flow State Investments’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,162
Closed -$426 232
2023
Q2
$426 Sell
10,162
-4,838
-32% -$329 ﹤0.01% 215
2023
Q1
$921 Buy
15,000
+4,967
+50% +$438 ﹤0.01% 191
2022
Q4
$752 Buy
+10,033
New +$680 ﹤0.01% 154

Other funds holding TLSIW

Flow State Investments's TLSIW Position: Q3 2023 in Review

Flow State Investments sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2023, closing a stake of 10,162 shares — an estimated $426 sold.

Flow State Investments first reported a position in TLSIW in Q4 2022 and held it in 3 quarters. The position peaked at $921 in Q1 2023. 19 funds tracked by Wall St. Rank hold TLSIW as of Q3 2023.

  • Flow State Investments reported no remaining TriSalus Life Sciences Warrant position as of Q3 2023 after selling out during the quarter.
  • Flow State Investments sold 10,162 TriSalus Life Sciences Warrant shares in Q3 2023, an estimated $426.
  • Flow State Investments first reported a position in TriSalus Life Sciences Warrant in Q4 2022 and held it in 3 quarters.
  • Flow State Investments's TriSalus Life Sciences Warrant position peaked at $921 in Q1 2023.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2023.

Based on Flow State Investments's 13F filing for Q3 2023, filed 14 Nov 2023.